Insiders · LTRN

LTRN insider transactions

Lantern Pharma Inc. (LTRN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for LTRN

• 25d
  Director Keyser D Jeffrey bought $100,001 worth of shares (48,544 units at $2.06), increasing direct ownership by 106% to 94,303 units (SEC Form 4)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 25d
  Director Schalop Lee Troy bought $100,001 worth of shares (48,544 units at $2.06) (SEC Form 4)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 146d
  SEC Form 4 filed by Director Silberstein David S.

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 146d
  SEC Form 4 filed by Director Chandru Vijay

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 146d
  SEC Form 4 filed by Director Schalop Lee Troy

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 146d
  SEC Form 4 filed by Director Keyser D Jeffrey

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 146d
  SEC Form 4 filed by Director Maccecchini Maria-Luisa

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 168d
  SEC Form 4 filed by Chief Scientific Officer Bhatia Kishor G.

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 168d
  SEC Form 4 filed by Chief Financial Officer Margrave David R.

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 258d
  SEC Form 4 filed by Director Chandru Vijay

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 258d
  SEC Form 4 filed by Director Keyser D Jeffrey

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 258d
  SEC Form 4 filed by Chief Financial Officer Margrave David R.

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 258d
  SEC Form 4 filed by Chief Scientific Officer Bhatia Kishor G.

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 258d
  SEC Form 4 filed by President & CEO Sharma Panna

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 258d
  SEC Form 4 filed by Director Silberstein David S.

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 292d
  SEC Form 4 filed by Director Schalop Lee Troy

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 313d
  SEC Form 3 filed by new insider Schalop Lee Troy

  3 - Lantern Pharma Inc. (0001763950) (Issuer)
• 360d
  Large owner Fletcher Aaron G.L. sold $123,600 worth of shares (40,000 units at $3.09) (SEC Form 4)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 360d
  Large owner Kreis Leslie W. sold $123,600 worth of shares (40,000 units at $3.09) (SEC Form 4)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 361d
  Large owner Fletcher Aaron G.L. sold $208,271 worth of shares (61,613 units at $3.38) (SEC Form 4)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 361d
  Large owner Kreis Leslie W. sold $208,271 worth of shares (61,613 units at $3.38) (SEC Form 4)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 375d
  Large owner Fletcher Aaron G.L. sold $168,419 worth of shares (56,237 units at $2.99) (SEC Form 4)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 375d
  Large owner Kreis Leslie W. sold $168,419 worth of shares (56,237 units at $2.99) (SEC Form 4)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 682d
  Director Keyser D Jeffrey exercised 3,832 in-the-money shares at a strike of $3.13 (SEC Form 4)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 691d
  SEC Form 4 filed by Director Keyser D Jeffrey

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 691d
  SEC Form 4 filed by Director Maccecchini Maria-Luisa

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 691d
  SEC Form 4 filed by Director Chandru Vijay

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 691d
  SEC Form 4 filed by President and CEO Sharma Panna

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 691d
  SEC Form 4 filed by Chief Financial Officer Margrave David R.

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 691d
  SEC Form 4 filed by Chief Scientific Officer Bhatia Kishor G.

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 691d
  SEC Form 4 filed by Director Silberstein David S.

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 741d
  Kreis Leslie W. sold $189,100 worth of shares (30,000 units at $6.30) (SEC Form 4)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 741d
  Fletcher Aaron G.L. sold $189,100 worth of shares (30,000 units at $6.30) (SEC Form 4)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 830d
  Fletcher Aaron G.L. sold $676,294 worth of shares (144,000 units at $4.70) (SEC Form 4)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 830d
  Kreis Leslie W. sold $676,294 worth of shares (144,000 units at $4.70) (SEC Form 4)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 871d
  Fletcher Aaron G.L. exercised 79,021 in-the-money shares at a strike of $3.13 and sold $247,334 worth of shares (58,889 units at $4.20) (SEC Form 4)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 871d
  Kreis Leslie W. exercised 79,021 in-the-money shares at a strike of $3.13 and sold $247,334 worth of shares (58,889 units at $4.20) (SEC Form 4)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 921d
  Kreis Leslie W. sold $499,997 worth of shares (145,348 units at $3.44) (SEC Form 4)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 921d
  Fletcher Aaron G.L. sold $499,997 worth of shares (145,348 units at $3.44) (SEC Form 4)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 1307d
  SEC Form 4: Kreis Leslie W. sold $1,540,000 worth of shares (350,000 units at $4.40)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 1307d
  SEC Form 4: Fletcher Aaron G.L. sold $1,540,000 worth of shares (350,000 units at $4.40)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 1323d
  SEC Form 4 filed by Maccecchini Maria-Luisa

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 1370d
  SEC Form 4: Fletcher Aaron G.L. exercised 32,538 in-the-money shares at a strike of $1.03 and sold $33,514 worth of shares (6,445 units at $5.20)

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 1370d
  SEC Form 4: Kreis Leslie W. sold $33,514 worth of shares (6,445 units at $5.20) and exercised 32,538 in-the-money shares at a strike of $1.03

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 1452d
  SEC Form 3 filed by new insider Maccecchini Maria-Luisa

  3 - Lantern Pharma Inc. (0001763950) (Issuer)
• 1540d
  SEC Form 4: Kreis Leslie W. exercised 95,779 in-the-money shares at a strike of $160,176.01

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 1673d
  SEC Form 4 filed by Kreis Leslie W.

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 1673d
  SEC Form 4 filed by Silberstein David S.

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 1673d
  SEC Form 4 filed by Chandru Vijay

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 1673d
  SEC Form 4 filed by Prendergast Franklyn G

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 1673d
  SEC Form 4 filed by Keyser D Jeffrey

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 1679d
  SEC Form 4 filed by Margrave David R.

  4 - Lantern Pharma Inc. (0001763950) (Issuer)
• 1966d
  SEC Form 4 filed by Llc Ii, Ventures Golf & Park Green

  4 - Lantern Pharma Inc. (0001763950) (Issuer)